These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36611124)

  • 41. Ordered Assembly of Tau Protein and Neurodegeneration.
    Goedert M; Spillantini MG
    Adv Exp Med Biol; 2019; 1184():3-21. PubMed ID: 32096024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Honda K; Saito Y; Saito H; Toyoda M; Abe R; Saito T; Saido TC; Michikawa M; Taru H; Sobu Y; Hata S; Nakaya T; Suzuki T
    Neurobiol Aging; 2023 Mar; 123():63-74. PubMed ID: 36638682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
    Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
    Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
    Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease.
    Armstrong P; Güngör H; Anongjanya P; Tweedy C; Parkin E; Johnston J; Carr IM; Dawson N; Clapcote SJ
    Neuropsychopharmacology; 2024 Sep; 49(10):1559-1568. PubMed ID: 38521860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein E genotype-dependent accumulation of amyloid β in APP-knock-in mouse model of Alzheimer's disease.
    Takebayashi Y; Yamazaki Y; Yamada H; Yazawa K; Nakamori M; Kurashige T; Morino H; Takahashi T; Sotomaru Y; Maruyama H
    Biochem Biophys Res Commun; 2023 Nov; 683():149106. PubMed ID: 37857162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single App knock-in mouse models of Alzheimer's disease.
    Saito T; Matsuba Y; Mihira N; Takano J; Nilsson P; Itohara S; Iwata N; Saido TC
    Nat Neurosci; 2014 May; 17(5):661-3. PubMed ID: 24728269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryo-EM structures of prion protein filaments from Gerstmann-Sträussler-Scheinker disease.
    Hallinan GI; Ozcan KA; Hoq MR; Cracco L; Vago FS; Bharath SR; Li D; Jacobsen M; Doud EH; Mosley AL; Fernandez A; Garringer HJ; Jiang W; Ghetti B; Vidal R
    Acta Neuropathol; 2022 Sep; 144(3):509-520. PubMed ID: 35819518
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau.
    Schweighauser M; Murzin AG; Macdonald J; Lavenir I; Crowther RA; Scheres SHW; Goedert M
    Acta Neuropathol Commun; 2023 Oct; 11(1):160. PubMed ID: 37798679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.
    Nilsberth C; Westlind-Danielsson A; Eckman CB; Condron MM; Axelman K; Forsell C; Stenh C; Luthman J; Teplow DB; Younkin SG; Näslund J; Lannfelt L
    Nat Neurosci; 2001 Sep; 4(9):887-93. PubMed ID: 11528419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis.
    Jiang R; Smailovic U; Haytural H; Tijms BM; Li H; Haret RM; Shevchenko G; Chen G; Abelein A; Gobom J; Frykman S; Sekiguchi M; Fujioka R; Watamura N; Sasaguri H; Nyström S; Hammarström P; Saido TC; Jelic V; Syvänen S; Zetterberg H; Winblad B; Bergquist J; Visser PJ; Nilsson P
    Acta Neuropathol Commun; 2022 Jul; 10(1):96. PubMed ID: 35787306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Temporal progression of Alzheimer's disease in brains and intestines of transgenic mice.
    Manocha GD; Floden AM; Miller NM; Smith AJ; Nagamoto-Combs K; Saito T; Saido TC; Combs CK
    Neurobiol Aging; 2019 Sep; 81():166-176. PubMed ID: 31284126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A highly insoluble state of Abeta similar to that of Alzheimer's disease brain is found in Arctic APP transgenic mice.
    Philipson O; Hammarström P; Nilsson KP; Portelius E; Olofsson T; Ingelsson M; Hyman BT; Blennow K; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2009 Sep; 30(9):1393-405. PubMed ID: 18192084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the App
    Andersson E; Schultz N; Saito T; Saido TC; Blennow K; Gouras GK; Zetterberg H; Hansson O
    Alzheimers Res Ther; 2023 Mar; 15(1):64. PubMed ID: 36964585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation.
    Cheng IH; Palop JJ; Esposito LA; Bien-Ly N; Yan F; Mucke L
    Nat Med; 2004 Nov; 10(11):1190-2. PubMed ID: 15502844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cryo-EM structures of τ filaments from human brain.
    Goedert M
    Essays Biochem; 2021 Dec; 65(7):949-959. PubMed ID: 34846514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice.
    Mowry FE; Espejo-Porras F; Jin S; Quadri Z; Wu L; Bertolio M; Jarvis R; Reynolds C; Alananzeh R; Bieberich E; Yang Y
    Neurobiol Dis; 2023 Aug; 184():106213. PubMed ID: 37364689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.